PALMITAMIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H33NO
Molecular Weight	255.4393
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCCCCCCCCCCCCCC(N)=O

InChI

InChIKey=HSEMFIZWXHQJAE-UHFFFAOYSA-N

InChI=1S/C16H33NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H2,17,18)

HIDE SMILES / InChI

Description
Sources: www.google.ch/patents/WO2008125805A1?cl=en | DOI 10.1007/s11515-016-1400-8 retrieved from https://link.springer.com/article/10.1007/s11515-016-1400-8

Palmitic acid amide (or palmitamide) is a primary fatty acid amide which was studied as a marker of the following diseases: schizophrenia and major depressive disorder.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Schizophrenia 298 Sources: https://patents.google.com/patent/WO2008125805A1	Diagnostic		Natural Metabolite	Unknown Approved Use Unknown
Major depressive disorder 173 Sources: DOI: 10.1007/s11515-016-1400-8	Diagnostic		Natural Metabolite	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
Condensation reactions and formation of amides, esters, and nitriles under hydrothermal conditions.	2004 Summer	15253839

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Name

Type

Language

PALMITAMIDE

Official Name

English

CETYL AMIDE

Systematic Name

English

PALMITIC ACID AMIDE

Systematic Name

English

PALMITAMIDE (PALMITIC ACID AMIDE)

Common Name

English

HEXADECANAMIDE

Systematic Name

English

PALMITAMIDE [INCI]

Common Name

English

NSC-3327

Code

English

Classification Tree Code System Code

CFR

21 CFR 181.28